Biotech grants
Explore grants for biotech companies. This directory brings together funding for therapeutics, diagnostics, platform technologies, bioprocessing and translational research, from health research agencies, national innovation programs, disease foundations and industry partnerships.
Showing 241-264 of 2,748 grants
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award
🇺🇸NIH · United States
Funds collaborative projects that build, test and spread new tools or methods across NIH's national network of clinical and translational research hubs.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery
NIH · United States
Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification
NIH · United States
Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies
NIH · United States
Funds the pharmacology and animal efficacy work that shows a neurological drug candidate is worth developing further.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01)
🇺🇸NIH · United States
Funds one investigator's discovery-to-proof-of-concept project on a new drug, ligand or neurostimulation device for a mental or substance use disorder.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19)
🇺🇸NIH · United States
Funds a coordinated multi-project program discovering and testing new drugs, ligands or neurostimulation devices for mental or substance use disorders.
WIPANO Patenting for Companies
🇩🇪BMWE · Germany
Funds German small and medium-sized enterprises protecting their own research and development results with patents and other industrial property rights through WIPANO.
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards
🇺🇸NIH · United States
Funds the renewal of a neurology clinical trial the institute already supports, where finishing it needs more time and resources.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
Toward Translation of Nanotechnology Cancer Interventions (TTNCI)
🇺🇸NIH · United States
Funds advanced preclinical work maturing a nanoparticle-based cancer diagnostic or therapeutic toward the National Cancer Institute's own translation pipeline.
Basic Research in Cancer Health Disparities (R21)
NIH · United States
Funds early-stage mechanistic work on the biological and genetic causes of cancer health disparities, on a shorter and smaller footing.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases
🇺🇸NIH · United States
Funds basic biochemical or biological work on a protein from a published list — druggable, linked to a rare disease, and barely studied.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK
🇺🇸NIH · United States
Funds pilot basic and translational work on HIV complications in the organs and processes the diabetes, digestive and kidney institute covers.
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
🇺🇸NIH · United States
Funds basic research on the harm caused by a single exposure to ultra-potent synthetic opioids, including the effects that appear later.
ARO Core BAA — Single Investigator
🇺🇸ARO · United States
Offers core basic research grants across physical, engineering, and information science domains in the Army.
ARO Early Career Program (YIP)
🇺🇸ARO · United States
Supports early-career faculty pursuing Army basic research through direct funding pathways.
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
🇺🇸NIH · United States
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification
🇺🇸NIH · United States
Funds identifying and validating a disease target, then finding a preliminary drug, biologic or combination-product lead against it.
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype
🇺🇸NIH · United States
Funds turning a preliminary drug, biologic or combination-product lead into a combination-product prototype for heart, lung, blood or sleep disease.
NHLBI Catalyze — Reissue
🇺🇸NHLBI · United States
Supports NHLBI translational pathways toward first-in-human feasibility testing.
A+ Early-Stage Startup Grant Program
🇹🇼ITRI · Taiwan
Funds Taiwan early-stage technology startups moving from functional prototype to MVP validation and market landing.
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the continuation of a dental clinical trial the institute already supports, or a competing revision that changes what it does.